Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups (Q44764021)

6 December 2017

Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups (English)

1 reference

6 December 2017

1 reference

5

Perlmutter JS

1 reference

6 December 2017

Parsian A

1

1 reference

6 December 2017

Racette B

series ordinal

2

1 reference

6 December 2017

Zhang ZH

series ordinal

3

1 reference

6 December 2017

Rundle M

series ordinal

4

1 reference

6 December 2017

1 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

83

1 reference

6 December 2017

3

1 reference

6 December 2017

454-460

1 reference

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Genetic Complexity and Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Association between early-onset Parkinson's disease and mutations in the parkin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Parkinson disease in twins: an etiologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Molecular genetics of the monoamine oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Relationship between platelet monoamine oxidase B activity and alleles at the MAOB locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

The effect of deprenyl and levodopa on the progression of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Experimental therapeutics of neurodegenerative disorders: unmet needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Platelet monoamine oxidase-B activity in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Association of a monoamine oxidase B allele with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

An allelic association study of monoamine oxidase B in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Evaluation of a screening questionnaire for genetic studies of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Monoamine oxidases and alcoholism. I. Studies in unrelated alcoholics and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2003.09.002

10.1016/J.YGENO.2003.09.002

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference